7 not yet recruiting, 5 completed, 2 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Caja Costarricense de Seguro Social: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical, Epidemiologic, and Therapeutic Characterization of Pediatric Psoriasis in the Costa Rican Social Security System Pediatric Psoriasis | Not yet recruiting | Caja Costarricense de Seguro Social | 300 | 2026-05-01 | 2026-04-07 | |
| Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica Abrocitinib, Upadacitinib, Baricitinib - Atopic Dermatitis, Atopic Dermatitis (AD) | Not yet recruiting | Caja Costarricense de Seguro Social | 50 | 2026-05-01 | 2026-04-08 | |
| Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica. Lymph Node Cancer, Cutaneous | Not yet recruiting | Caja Costarricense de Seguro Social | 350 | 2026-05-01 | 2026-04-20 | |
| Psoriasis Comorbidities at Hospital Calderón Guardia Psoriasis, Psoriasis Arthritis | Not yet recruiting | Caja Costarricense de Seguro Social | 350 | 2026-05-01 | 2026-04-08 | |
| Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025) Leprosy, Hansen's Disease | Not yet recruiting | Caja Costarricense de Seguro Social | 130 | 2026-05-01 | 2026-03-09 | |
| Generalized Pustular Psoriasis Registry in Costa Rica Generalized Pustular Psoriasis, Generalized Pustular Psoriasis (GPP) | Not yet recruiting | Caja Costarricense de Seguro Social | 50 | 2026-05-01 | 2026-03-09 | |
| Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease Guselkumab (GUS), Risankizumab (RISA) - Psoriasis, Psoriasis Arthritis | Not yet recruiting | Caja Costarricense de Seguro Social | 50 | 2026-05-01 | 2026-03-09 | |
| A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica. Sporotrichosis, Chromomycosis | Completed | Caja Costarricense de Seguro Social | 95 | 2023-12-11 | 2024-07-29 | |
| Promoting Early Language Development Through Parent-child Book Reading in Costa Rica Interactive Book Reading - Language Development | Not applicable | Completed | Universidad de Costa Rica | 184 | 2021-08-13 | 2023-12-15 |
| Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients Anti SARS-CoV-2 equine hyperimmune serum, placebo - Covid19 | Phase 2 / Phase 3 | Unknown | Caja Costarricense de Seguro Social | 156 | 2021-03-29 | 2021-05-21 |
| Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica 1. Characterize the immune response after infection with SARS-CoV-2 - COVID-19 | Unknown | Agencia Costarricense de Investigaciones Biomedicas | 2000 | 2020-09-14 | 2020-09-03 | |
| Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Administration of Equine immunoglobulin anti SARS-CoV-2 - Covid19 | Phase 2 | Completed | Caja Costarricense de Seguro Social | 26 | 2020-09-06 | 2021-03-19 |
| Implementation of an Epidemiological and Clinical Registry of Emergency Surgery Patients in a Costa Rican Hospital Abdominal surgery - Surgical Complication, Emergencies | Completed | Caja Costarricense de Seguro Social | 575 | 2020-05-01 | 2023-07-05 | |
| Primary Immunodeficiencies in Costa Rican Adults Primary Immune Deficiency in Adults | Completed | Caja Costarricense de Seguro Social | 137 | 2018-11-11 | 2021-07-15 |
Psoriasis (4) · COVID-19 (3) · Actinomycosis (1) · Bacterial Infections and Mycoses (1) · Blastomycosis (1) · Chromoblastomycosis (1) · Coccidioidomycosis (1) · Dermatitis, Atopic (1) · Eczema (1) · Emergencies (1) · Leprosy (1) · Leprosy, Lepromatous (1) · Leprosy, Multibacillary (1) · Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Cutaneous (1)
abrocitinib (1) · baricitinib (1) · dupilumab (1) · guselkumab (1) · risankizumab (1) · upadacitinib (1)
Costa Rica (13)
Alfredo Sanabria, PhD (1) · Ana M. Carmiol, PhD (1) · Daniel E Barquero Orias, MD (1) · Rolando Herrerro, Médico (1) · Willem Bujan, MBA (1)
PMID 18624603, PMID 27266965, PMID 27717614, PMID 36700518, PMID 38070892, PMID 40102764, PMID 42415008